Xu Q - Search Results

1

HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.

Fang DD, Zhang B, Gu Q, Lira M, Xu Q, Sun H, Qian M, Sheng W, Ozeck M, Wang Z, Zhang C, Chen X, Chen KX, Li J, Chen SH, Christensen J, Mao M, Chan CC. Fang DD, et al. Among authors: xu q. J Thorac Oncol. 2014 Mar;9(3):285-94. doi: 10.1097/JTO.0000000000000087. J Thorac Oncol. 2014. PMID: 24496003 Free article.

2

Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development.

Gu Q, Zhang B, Sun H, Xu Q, Tan Y, Wang G, Luo Q, Xu W, Yang S, Li J, Fu J, Chen L, Yuan S, Liang G, Ji Q, Chen SH, Chan CC, Zhou W, Xu X, Wang H, Fang DD. Gu Q, et al. Among authors: xu q, xu w, xu x. Oncotarget. 2015 Aug 21;6(24):20160-76. doi: 10.18632/oncotarget.3969. Oncotarget. 2015. PMID: 26062443 Free PMC article.

3

Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma.

Yang S, Luo C, Gu Q, Xu Q, Wang G, Sun H, Qian Z, Tan Y, Qin Y, Shen Y, Xu X, Chen SH, Chan CC, Wang H, Mao M, Fang DD. Yang S, et al. Among authors: xu q, xu x. Oncotarget. 2016 Feb 2;7(5):5461-9. doi: 10.18632/oncotarget.6684. Oncotarget. 2016. PMID: 26701727 Free PMC article.

4

Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients.

Tan Q, Li F, Wang G, Xia W, Li Z, Niu X, Ji W, Yuan H, Xu Q, Luo Q, Zhang J, Lu S. Tan Q, et al. Among authors: xu q. Oncotarget. 2016 Apr 5;7(14):18394-402. doi: 10.18632/oncotarget.7817. Oncotarget. 2016. PMID: 26943773 Free PMC article.

5

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer.

Zang YS, Dai C, Xu X, Cai X, Wang G, Wei J, Wu A, Sun W, Jiao S, Xu Q. Zang YS, et al. Among authors: xu q, xu x. Cancer Med. 2019 Aug;8(10):4699-4708. doi: 10.1002/cam4.2381. Epub 2019 Jul 4. Cancer Med. 2019. PMID: 31270941 Free PMC article.

6

Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L.

Song C, Xu Q, Jiang K, Zhou G, Yu X, Wang L, Zhu Y, Fang L, Yu Z, Lee JD, Yu SC, Yang Q. Song C, et al. Among authors: xu q. Oncotarget. 2015 Oct 20;6(32):33279-89. doi: 10.18632/oncotarget.5337. Oncotarget. 2015. PMID: 26432836 Free PMC article.

7

Using clinical genomic sequencing to guide personalized cancer therapy in China.

Bai Y, Wang G, Wei J, Dai C, Xu X, Cai X, Wu B, Sun W, Xu Q, Jiao S. Bai Y, et al. Among authors: xu q, xu x. Per Med. 2019 Jul;16(4):287-299. doi: 10.2217/pme-2018-0056. Epub 2019 Mar 21. Per Med. 2019. PMID: 30895868

8

A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway.

Peng L, Zhao M, Liu T, Chen J, Gao P, Chen L, Xing P, Wang Z, Di J, Xu Q, Qu H, Jiang B, Su X. Peng L, et al. Among authors: xu q. Cell Death Dis. 2022 Apr 22;13(4):395. doi: 10.1038/s41419-022-04844-3. Cell Death Dis. 2022. PMID: 35459861 Free PMC article.

9

Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma.

Song C, Wang L, Xu Q, Wang K, Xie D, Yu Z, Jiang K, Liao L, Yates JR, Lee JD, Yang Q. Song C, et al. Among authors: xu q. Sci Rep. 2017 Apr 7;7:46244. doi: 10.1038/srep46244. Sci Rep. 2017. PMID: 28387310 Free PMC article.

10

Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors.

Li J, Jiang W, Wei J, Zhang J, Cai L, Luo M, Wang Z, Sun W, Wang S, Wang C, Dai C, Liu J, Wang G, Wang J, Xu Q, Deng Y. Li J, et al. Among authors: xu q. J Transl Med. 2020 Aug 1;18(1):293. doi: 10.1186/s12967-020-02449-y. J Transl Med. 2020. PMID: 32738923 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,371 results

Search Page

Filters